U.S. Annual Flu Report

The 2018 Influenza Vaccine Production & Distribution market report provides new insights into the flu products supply chain and key information from the eighth annual "Flu Products Survey" of distributors conducted in May 2018. The survey demonstrates the essential role that distributors will serve during the 2018-2018 flu season by helping healthcare facilities and patients access vaccines, hypodermic supplies, diagnostic tests, and more.

Takeaways From The 2018 Flu Market Brief

The 2018 Influenza Vaccine Production & Distribution market report provides new insights into the flu products supply chain and key information from the eighth annual "Flu Products Survey" of distributors conducted in May 2018. The survey demonstrates the essential role that distributors will serve during the 2018-2019 flu season by helping healthcare facilities and patients access vaccines, hypodermic supplies, diagnostic tests, and more.

The 2017-2018 influenza season occurred from October 1, 2017 to May 19, 2018. This past season was considered a high severity season with high levels of outpatient clinic and emergency department visits for influenza-like illness, high influenza-related hospitalization rates, and elevated geographically widespread influenza activity across the country for an extended period of time.

National activity began growing in November. There was an extended period of high activity in January and February which remained elevated through March. Influenza A (H3N2) virus was predominant through February with influenza B viruses more common beginning in March through the end of the season. The healthcare supply chain demonstrated flexibility and efficiency through 24-48 hour delivery and logistical expertise to ensure healthcare providers were well supplied throughout the flu season.

Additionally, the 2018 Influenza Vaccine Production & Distribution market report provides key information on:

• Flu vaccine production, supply, and allocation
• Patient and physician vaccination trends
• Managing influenza with diagnostic resources
• Manufacturing and distribution processes
• Medicare reimbursement
• Quality reporting measures related to influenza vaccination
• Vaccine effectiveness trends.

Who Should Read This Report

This report is intended for several key audiences: senior sales, marketing, and strategy executives of healthcare distribution and manufacturing companies, as well as healthcare sales staff in the field. Stakeholders in the influenza vaccine supply chain and government agencies responsible for the public health and oversight of the production and distribution of influenza vaccines will also find this report of interest.